Covid-19: Novavax vaccine shows 89% efficacy in UK trials
Published
The vaccine is the first to show in trials that it is effective against the UK variant of the virus.
Full ArticlePublished
The vaccine is the first to show in trials that it is effective against the UK variant of the virus.
Full ArticleUK phase three trials of the experimental Novavax COVID-19 vaccine have found it demonstrated 89.3% efficacy against the virus.